|
|
Blood, 22 January 2009, Vol. 113, No. 4, pp. 816-826.
Prepublished online as a Blood First Edition Paper on September 25, 2008; DOI 10.1182/blood-2007-12-128702.
Previous Article | Table of Contents | Next Article 
HEMATOPOIESIS AND STEM CELLS
The CD34-like protein PODXL and 6-integrin (CD49f) identify early progenitor MSCs with increased clonogenicity and migration to infarcted heart in mice
Ryang Hwa Lee1,*,
Min Jeong Seo1,*,
Andrey A. Pulin1,
Carl A. Gregory1,
Joni Ylostalo1, and
Darwin J. Prockop1
1 Center for Gene Therapy, Tulane University Health Sciences Center, New Orleans, LA
We screened for surface proteins expressed only by the early progenitor cells present in low-passage, low-density cultures of the adult stem/progenitor cells from bone marrow referred to as mesenchymal stem cells or multipotent stromal cells (MSCs). Six proteins were identified that were selectively expressed in the early progenitors: podocalyxin-like protein (PODXL), 6-integrin (CD49f), 4-integrin (CD49d), c-Met, CXCR4, and CX3CR1. All were previously shown to be involved in cell trafficking or tumor progression. Antibodies to CD49f and PODXL, a sialomucin in the CD34 family, were the most robust for FACScan assays. PODXLhi/CD49fhi MSCs were more clonogenic and differentiated more efficiently than PODXLlo/CD49flo cells. Inhibition of expression of PODXL with RNA interference caused aggregation of the cells. Furthermore, PODXLhi/CD49fhi MSCs were less prone to produce lethal pulmonary emboli, and larger numbers were recovered in heart and kidney after intravenous infusion into mice with myocardial infarcts.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
|
|